These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29895155)

  • 1. USP15 inhibits HPV16 E6 degradation and catalytically inactive USP15 has reduced inhibitory activity.
    Yaginuma Y; Yoshimoto M; Tokuda A
    Acta Virol; 2018; 62(2):147-156. PubMed ID: 29895155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
    Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
    FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ubiquitin-specific peptidase USP15 regulates human papillomavirus type 16 E6 protein stability.
    Vos RM; Altreuter J; White EA; Howley PM
    J Virol; 2009 Sep; 83(17):8885-92. PubMed ID: 19553310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling.
    Chiang C; Pauli EK; Biryukov J; Feister KF; Meng M; White EA; Münger K; Howley PM; Meyers C; Gack MU
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
    Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
    Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A transcriptomic landscape of human papillomavirus 16 E6-regulated gene expression and splicing events.
    Xu J; Fang Y; Qin J; Chen X; Liang X; Xie X; Lu W
    FEBS Lett; 2016 Dec; 590(24):4594-4605. PubMed ID: 27859058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53.
    Niebler M; Qian X; Höfler D; Kogosov V; Kaewprag J; Kaufmann AM; Ly R; Böhmer G; Zawatzky R; Rösl F; Rincon-Orozco B
    PLoS Pathog; 2013; 9(8):e1003536. PubMed ID: 23935506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides.
    Stutz C; Reinz E; Honegger A; Bulkescher J; Schweizer J; Zanier K; Travé G; Lohrey C; Hoppe-Seyler K; Hoppe-Seyler F
    PLoS One; 2015; 10(7):e0132339. PubMed ID: 26151636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human papillomavirus (HPV) E6 oncoproteins promotes nuclear localization of active caspase 8.
    Manzo-Merino J; Massimi P; Lizano M; Banks L
    Virology; 2014 Feb; 450-451():146-52. PubMed ID: 24503077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of p53 by HPV16-E6 variants isolated from cervical cancer specimens of Moroccan women.
    Hadami K; Saby C; Dakka N; Collin G; Attaleb M; Khyatti M; Filali-Maltouf A; Morjani H; El Mzibri M
    Gene; 2021 Jul; 791():145709. PubMed ID: 33984442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus 16 E6 and E7 oncoprotein expression alters microRNA expression in extracellular vesicles.
    Harden ME; Munger K
    Virology; 2017 Aug; 508():63-69. PubMed ID: 28500882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression.
    Poirson J; Suarez IP; Straub ML; Cousido-Siah A; Peixoto P; Hervouet E; Foster A; Mitschler A; Mukobo N; Chebaro Y; Garcin D; Recberlik S; Gaiddon C; Altschuh D; Nominé Y; Podjarny A; Trave G; Masson M
    J Virol; 2022 May; 96(10):e0187521. PubMed ID: 35475668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High risk HPV E6 oncoproteins impair the subcellular distribution of the four and a half LIM-only protein 2 (FHL2).
    Manzo-Merino J; Massimi P; Banks L; Lizano M
    Virology; 2015 Feb; 476():100-105. PubMed ID: 25540819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Regulations of Deubiquitinase USP15 and Its Pathophysiological Mechanisms in Diseases.
    Chou CK; Chang YT; Korinek M; Chen YT; Yang YT; Leu S; Lin IL; Tang CJ; Chiu CC
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Deubiquitinase USP46 Is Essential for Proliferation and Tumor Growth of HPV-Transformed Cancers.
    Kiran S; Dar A; Singh SK; Lee KY; Dutta A
    Mol Cell; 2018 Dec; 72(5):823-835.e5. PubMed ID: 30415951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6.
    Xu J; Wan X; Chen X; Fang Y; Cheng X; Xie X; Lu W
    Sci Rep; 2016 Jul; 6():28968. PubMed ID: 27364926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin ligase E6AP mediates nonproteolytic polyubiquitylation of β-catenin independent of the E6 oncoprotein.
    Kuslansky Y; Sominsky S; Jackman A; Gamell C; Monahan BJ; Haupt Y; Rosin-Arbesfeld R; Sherman L
    J Gen Virol; 2016 Dec; 97(12):3313-3330. PubMed ID: 27902311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transactivation activity of human papillomavirus type 16 E6*I on aldo-keto reductase genes enhances chemoresistance in cervical cancer cells.
    Wanichwatanadecha P; Sirisrimangkorn S; Kaewprag J; Ponglikitmongkol M
    J Gen Virol; 2012 May; 93(Pt 5):1081-1092. PubMed ID: 22278827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.